Sign in

CIK 0000882796 · Large accelerated filer

BIOCRYST PHARMACEUTICALS INC

Sign in to watch
Ticker
BCRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
621413174
Phone
919-859-1302
Business address
4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
  1. 4 Grant or award Director acquired 1,138 shares (grant or award)
  2. 4 Grant or award Director acquired 2,078 shares (grant or award)
  3. DEFA14A Proxy Proxy Materials
  4. 10-Q Report Quarterly Report
  5. 8-K Event Results of operations · Regulation FD disclosure
  6. DEFA14A Proxy Proxy Materials
  7. DEF 14A Proxy Proxy Statement
  8. 4 Open-market sale Director sold 5,000 shares at $11.04 ($55,200)
  9. 8-K Event Regulation FD disclosure
  10. 8-K Event Other events
  11. 4 Open-market sale Chief R&D Officer sold 7,600 shares at $16.20 ($123,120)
  12. 4 Open-market sale Chief Medical Officer sold 161,139 shares at an average $16.88 ($2,719,493)
  13. 4 Open-market sale Chief Discovery Officer sold 20,000 shares at $17.16 ($343,200)
  14. 4 Open-market sale Exec. Director, Finance - PAO sold 2,300 shares at $17.20 ($39,560)
  15. 4 Grant or award Director acquired 602 shares (grant or award)
  16. 4 Grant or award Director acquired 1,128 shares (grant or award)
  17. 4 Grant or award Director acquired 602 shares (grant or award)
  18. 4 Grant or award Director acquired 301 shares (grant or award)
  19. 10-K Report Annual Report
  20. 8-K Event Results of operations · Regulation FD disclosure

Page 18 of 99 · 1,967 filings